ResMed (ASX:RMD)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResMed.
RELATED STOCKHEAD STORIES
Health Check: Don’t dis-May! ASX biotechs record strong year-on-year share gains
Scott Power: ASX health stocks rise as Healthscope landlord agrees to rent deferral deal
Health Check: Fisher & Paykel Healthcare defies the hospital cost crunch with record revenue
Share Tips: This week’s buy, hold and sell recommendations
Scott Power: ASX health stocks rise with capital raisings in full swing
Health Check: Investors catch a falling knife as biotech big names bounce from lows
Closing Bell: ASX leaps as traders pile into miners; copper price boosted after Peru incident
Health Check: Snore-buster Resmed says miracle diet drugs and tariffs no threat to growth
Scott Power: ASX health stocks up in strong start to reporting season
Lunch Wrap: ASX lifts and miners bounce back after tariff de-escalation
Big pharma Sandoz steps into Aussie CBD scene; could this be the start of a rush?
Health Check: We’re ‘duty free’, declare several ASX life science companies
Criterion: Liberation Day delivers some not so tariff-ic share surprises
